Product Name:Procarbazine hydrochloride
IUPAC Name:4-[(2-methylhydrazin-1-yl)methyl]-N-(propan-2-yl)benzamide hydrochloride
Product Overview |
Procarbazine hydrochloride (PCZ-HCl) is a synthetic antineoplastic drug used in the treatment of Hodgkin’s lymphoma, a type of cancer. It is a derivative of the natural product procarbazine and has been used in medical practice since the 1960s. |
Physical Properties |
PCZ-HCl is a white to off-white crystalline powder that is soluble in water. |
Chemical Properties |
Procarbazine hydrochloride has the advantages of using in laboratory experiments include its ease of use, its availability, its low cost, and its ability to be used in a variety of experiments. The main limitation is its toxicity. |
Synthesis and Application |
Procarbazine hydrochloride is used in a number of in vivo studies to investigate its mechanism of action and biological activity. It has been used to study its effects on cancer cells, its ability to inhibit monoamine oxidase, and its ability to induce apoptosis. It has also been used to study its effects on the immune system, its ability to inhibit the growth of tumors, and its ability to cause DNA damage. Procarbazine hydrochloride has been used in a number of in vitro studies to investigate its mechanism of action and biological activity. It has been used to study its effects on cancer cells, its ability to inhibit monoamine oxidase, and its ability to induce apoptosis. It has also been used to study its effects on the immune system, its ability to inhibit the growth of tumors, and its ability to cause DNA damage. |
Future Directions |
1.Further research into the mechanism of action of Procarbazine hydrochloride and its effects on the body. 2. Further research into the potential therapeutic applications of Procarbazine hydrochloride. 3. Investigation of the potential of Procarbazine hydrochloride to be used in combination with other drugs to increase its efficacy. |